HECTD1 and androgen insensitivity syndrome: This may be explained by the following: CircRNA HECTD1 may enlarge infarct size, aggregate neuron deficits, and trigger inflammation, resulting in a higher AIS risk.7, 8 Thus, circRNA HECTD1 might be used as a novel biomarker in predicting AIS risk.